Cost-Utility Analysis Of Rosuvastatin Compared To Atorvastatin In Primary Prevention Of Myocardial Infarction Among HIV-Positive Patients On Haart In Uganda
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.1619
https://www.valueinhealthjournal.com/article/S1098-3015(17)31953-8/fulltext
Title :
Cost-Utility Analysis Of Rosuvastatin Compared To Atorvastatin In Primary Prevention Of Myocardial Infarction Among HIV-Positive Patients On Haart In Uganda
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)31953-8&doi=10.1016/j.jval.2017.08.1619
First page :
A666
Section Title :
Health Care Use & Policy Studies
Open access? :
No
Section Order :
1456